Wahed Invest’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18.6M Buy
20,185
+900
+5% +$912K 2.41% 9
2025
Q4
$20.7M Buy
+19,285
New +$18.4M 2.73% 8
2024
Q2
Sell
-16,660
Closed -$13M 239
2024
Q1
$13M Buy
16,660
+2,231
+15% +$1.59M 2.96% 6
2023
Q4
$8.41M Buy
14,429
+964
+7% +$563K 2.36% 7
2023
Q3
$7.23M Buy
13,465
+1,168
+9% +$602K 2.35% 8
2023
Q2
$5.77M Buy
12,297
+1,551
+14% +$650K 2.03% 9
2023
Q1
$3.69M Buy
10,746
+10
+0.1% +$3.37K 1.6% 11
2022
Q4
$3.93M Buy
10,736
+1,104
+11% +$391K 2.04% 8
2022
Q3
$3.12M Buy
9,632
+665
+7% +$211K 1.9% 9
2022
Q2
$2.91M Sell
8,967
-1,016
-10% -$305K 1.79% 10
2022
Q1
$2.86M Sell
9,983
-120
-1% -$30.9K 1.68% 8
2021
Q4
$2.79M Buy
+10,103
New +$2.56M 1.55% 12

Other funds holding LLY

Wahed Invest's LLY Position: Q1 2026 in Review

Wahed Invest increased its Eli Lilly (LLY) stake by 4.7% in Q1 2026, buying an estimated $912K and bringing the position to 20,185 shares worth $18.6M. The position accounts for 2.41% of the portfolio, ranked #9.

Wahed Invest first reported a position in LLY in Q4 2021 and has held it in 12 quarters since. The position peaked at $20.7M in Q4 2025. 4,356 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Wahed Invest held 20,185 shares of Eli Lilly worth $18.6M as of Q1 2026.
  • Wahed Invest bought 900 Eli Lilly shares in Q1 2026, an estimated $912K.
  • Eli Lilly made up 2.41% of Wahed Invest's portfolio in Q1 2026, its #9 holding.
  • Wahed Invest first reported a position in Eli Lilly in Q4 2021 and has held it in 12 quarters since.
  • Wahed Invest's Eli Lilly position peaked at $20.7M in Q4 2025.
  • 4,356 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Wahed Invest's 13F filing for Q1 2026, filed 13 May 2026.